1. "2020"
Formats
  1. Journal Article (2337)
  2. Meeting Abstract (1901)
  3. Review (494)
  4. Editorial (342)
  5. Correspondence (121)
  6. Guidelines (114)
  7. Book Section (99)
  8. Research Letter (95)
  9. Miscellaneous (61)
  10. Conference Paper (33)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2560)
  2. Solid Tumor Oncology Division (1535)
  3. GSK Faculty (1257)
  4. Sloan Kettering Institute Postdocs (1240)
  5. Hematologic Malignancies, Division of (936)
  6. Survivorship Research (930)

More Groups

People
  1. Jorge Reis-Filho (93)
  2. Miguel-Angel Perales (93)
  3. Sergio Giralt (91)
  4. Alexander Drilon (81)
  5. Britta Weigelt (76)
  6. Nadeem Abu-Rustum (71)

More People

Years
  1. 2020 (5599)
Publications
  1. Journal of Clinical Oncology (500)
  2. Blood (212)
  3. Cancer Research (185)
  4. Annals of Oncology (152)
  5. International Journal of Radiation Oncology, Biology, Physics (129)
  6. Laboratory Investigation (116)

More Publications

Publishers
  1. Elsevier Inc. (714)
  2. American Society of Clinical Oncology (548)
  3. Nature Publishing Group (385)
  4. American Association for Cancer Research (357)
  5. Oxford University Press (356)
  6. Springer (342)

More Publishers

Results (5599)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PET-directed chemoradiation (CRT) with induction FOLFOX compared to induction carboplatin/paclitaxel (CP) in patients with locally advanced esophageal adenocarcinoma (EA)
    Meeting Abstract

    Carr, R.; Hsu, M.; Tan, K. S.; Bains, M. S.; Bott, M.; Ilson, D. H.; Isbell, J. M.; Janjigian, Y. Y.; Maron, S. B.; Park, B.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A multicenter phase II study of nivolumab +/- ipilimumab for patients with metastatic sarcoma (Alliance A091401): Results of expansion cohorts
    Meeting Abstract

    Chen, J. L.; Mahoney, M. R.; George, S.; Antonescu, C. R.; Liebner, D. A.; Van Tine, B. A.; Milhem, M. M.; Tap, W. D.; Streicher, H.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase I/II study of SAR439859, an oral selective estrogen receptor degrader (SERD), in estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (mBC)
    Meeting Abstract

    Campone, M.; Bardia, A.; Ulaner, G. A.; Chandarlapaty, S.; Gosselin, A.; Doroumian, S.; Pelekanou, V.; Celanovic, M.; Linden, H. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Chi, P.; Qin, L. X.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B.; Crago, A. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Olaparib treatment in patients (pts) with platinum-sensitive relapsed (PSR) ovarian cancer (OC) by BRCA mutation (BRCAm) and homologous recombination deficiency (HRD) status: Phase II LIGHT study
    Meeting Abstract

    Cadoo, K. A.; Simpkins, F.; Mathews, C. A.; Kabil, N.; Bennett, J.; Aghajanian, C.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Temozolomide-induced hypermutation is associated with high-grade transformation, distant recurrence, and reduced survival after transformation in initially low-grade IDH-mutant diffuse gliomas
    Meeting Abstract

    Bush, N. A. O.; Yu, Y.; Villanueva-Meyer, J.; Grimmer, M.; Hilz, S.; Solomon, D.; Choi, S.; Mazor, T.; Hong, C.; Shai, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Characterization of patients with multiple primary tumors
    Meeting Abstract

    Cadoo, K. A.; Mukherjee, S.; Khurram, A.; Kemel, Y.; Tkachuk, K.; Liu, Y. L.; Carlo, M. I.; Walsh, M. F.; Latham, A.; Dubard-Gault, M. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Alliance A071401: Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations
    Meeting Abstract

    Brastianos, P. K.; Twohy, E.; Gerstner, E. R.; Kaufmann, T. J.; Iafrate, A. J.; Jeyapalan, S. A.; Piccioni, D. E.; Lassman, A. B.; Fadul, C. E.; Schiff, D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers
    Meeting Abstract

    Burman, B.; Sherman, E. J.; Kriplani, A.; Michel, L. S.; Dunn, L.; Fetten, J. V.; Warner, E.; Grewal, R. K.; Sabra, M.; Tuttle, R. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • CX-2009, a CD166-directed probody drug conjugate (PDC): Results from the first-in-human study in patients (Pts) with advanced cancer including breast cancer (BC)
    Meeting Abstract

    Boni, V.; Burris, H. A. 3rd; Liu, J. F.; Spira, A. I.; Arkenau, H. T.; Fidler, M. J.; Rosen, L. S.; Sweis, R. F.; Uboha, N. V.; Sanborn, R. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save